我院125例住院患者使用丹参酮IIA磺酸钠注射液的安全性分析

2016-11-09 23:04:14石晓萍李静潘雯吕迁洲
上海医药 2016年19期
关键词:他汀类药物安全性

石晓萍+李静+潘雯+吕迁洲

摘 要 目的:对丹参酮IIA磺酸钠注射液上市后的安全性进行评价,保障患者用药安全。 方法:收集并详细记录我院神经内科和内分泌科2015年9月—2016年3月使用丹参酮IIA磺酸钠注射液患者的用药情况以及安全性相关信息,采用描述性分析法总结分析发生不良事件的可能原因。结果:共收集了125例病例,未观察到严重不良事件发生,其中有7例患者发生了轻度不良事件,占5.6%。观察到的不良事件包括4例肝脏转氨酶水平异常升高,1例转氨酶水平异常升高伴粪隐血可疑阳性,1例转氨酶水平异常升高伴右前臂上臂瘀斑,1例出现左眼结膜出血,7例患者在使用丹参酮IIA磺酸钠注射液期间均联用其他可能导致该不良事件发生的药物如他汀类药物、抗栓药物等。结论:丹参酮IIA磺酸钠注射液总体安全性良好,但与他汀类药物和抗栓药物合用时仍需加强药学监护。

关键词 丹参酮IIA磺酸钠 安全性 他汀类药物 出血 不良事件

中图分类号:R286 文献标识码:C 文章编号:1006-1533(2016)19-0058-06

Safety analysis of sodium tanshinone IIA sulfonate injection in the treatment of 125 cases of inpatients*

SHI Xiaoping**, LI Jing, PAN Wen, LV Qianzhou***(Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China)

ABSTRACT Objective: To evaluate the safety of the marketed sodium tanshinone IIA sulfonate injection and to ensure the safety of medication. Methods: The information about the clinical applications and safety of sodium tanshinone IIA sulfonate injection used in department of neurology and endocrinology from September, 2015 to March, 2016 was collected and recorded in detail and the possible reasons of adverse events were analyzed by descriptive analysis. Results: One hundred and twentyfive cases of inpatients were collected, however, severe adverse events were not observed, among which mild adverse events occurred in 7 patients, accounting for 5.6%. There were 4 cases with the abnormal elevation of serum aminotransferase level, 1 case with the abnormal elevation of serum aminotransferase level and also with suspected positive fecal occult blood, 1 case with the abnormal elevation of serum aminotransferase level and also with right forearm ecchymosis, and 1 case with left eye conjunctival hemorrhage. These patients were administered with statins and antithrombotic drugs which may lead to such adverse events occurred when they underwent the treatment of sodium tanshinone IIA sulfonate injection. Conclusion: Overall, sodium tanshinone IIA sulfonate injection has a good safety, however, pharmaceutical care should be strengthened when it is used in combination with statins and antithrombotic drugs.

KEY WORDS sodium tanshinone IIA sulfonate; safety; statins; bleeding; adverse event

丹参酮IIA磺酸钠(sodium tanshinone IIA sulfonate,STS)是由唇形科植物丹参中分离的二萜醌类化合物丹参酮IIA经磺化后所得产物,水溶性好,生物利用度高,临床常用于冠心病、心绞痛、心肌梗死的辅助治疗,近年文献报道其对脑梗死、糖尿病周围神经病变、急性脑出血、椎基底动脉供血不足、肾功能衰竭等也具有一定疗效[1-5],故临床得以推广使用。但该药上市后在广泛人群中的用药安全性以及其在联合用药时的相互作用、配伍禁忌等方面仍有待进一步研究。……

登录APP查看全文

猜你喜欢
他汀类药物安全性
两款输液泵的输血安全性评估
既有建筑工程质量安全性的思考
某既有隔震建筑检测与安全性鉴定
米氮平治疗老年失眠伴抑郁症的疗效及安全性
三种他汀类药物对老年冠心病合并高胆固醇血症患者血脂水平的影响
他汀类联合心血管药物治疗冠心病的疗效观察
他汀类药物对冠心病PCI干预患者血脂及心血管事件风险的影响
关于不同剂量他汀治疗急性冠脉综合征患者急性期疗效临床分析
今日健康(2016年12期)2016-11-17 12:45:21
他汀类药物在临床用药中的合理性和安全性
今日健康(2016年12期)2016-11-17 12:09:13
ApplePay横空出世 安全性遭受质疑 拿什么保护你,我的苹果支付?